Wrist flexor muscle spasticity in stroke patients. Vascular syndromes of brain in cerebrovascular diseases
Conditions
Interventions
Intervention 1: Intervention group: Dry needling therapy. Intervention 2: Intervention group: Shockwave therapy. Intervention 3: Control group: Routine physiotherapy.
Sponsors
Tabriz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
40 Years to No maximum
Inclusion criteria
Inclusion criteria: Individuals with stroke aged over 40 years Individuals with unilateral hemiplegia with an onset of more than six months Individuals with wrist flexor muscle spasticity with an MMAS = 1 Individuals who are conscious and free of cognitive and perceptual impairments
Exclusion criteria
Exclusion criteria: Individuals with contraindications related to dry needling treatment, which include fear of or unwillingness to undergo needling, individuals with cognitive impairment or lack of understanding regarding needles, local or systemic infection, local edema in the area, vascular disease, women in the first trimester of pregnancy, and individuals with immune system disorders Individuals with contraindications related to shockwave therapy, including active infections such as osteomyelitis, malignant tumors, pregnancy, cardiac pacemakers or any implanted devices, the use of non-steroidal anti-inflammatory drugs (NSAIDs), the use of anticoagulant medications, and a history of corticosteroid injection at the treatment site Patients with spasticity accompanied by other neurological disorders Individuals with fixed muscle contracture in the wrist flexor group Individuals with a history of botulinum toxin injection within the past six months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Grade of spasticity. Timepoint: At the beginning of the study (before the start of the intervention) / after completing all treatment sessions / one month after the last treatment session. Method of measurement: Modified modified ashworth scale (MMAS). | — |
Secondary
| Measure | Time frame |
|---|---|
| Upper limb motor function. Timepoint: At the beginning of the study (before the start of the intervention) / after completing all treatment sessions / one month after the last treatment session. Method of measurement: The Persian version of the Fugl-Meyer Assessment.;Physical impairment and disability. Timepoint: At the beginning of the study (before the start of the intervention) / after completing all treatment sessions / one month after the last treatment session. Method of measurement: chedoke assessment tool(7 item version).;Level of motor recovery. Timepoint: At the beginning of the study (before the start of the intervention) / after completing all treatment sessions / one month after the last treatment session. Method of measurement: Brunnstrom Scale.;Active wrist extension range of motion. Timepoint: At the beginning of the study (before the start of the intervention) / after completing all treatment sessions / one month after the last treatment session. Method of measurement: Goniometry.;Passive wrist extension range of motion. Timepoint: At the beginning of the study (before the start of the intervention) / after completing all treatment sessions / one month after the last treatment session. Method of measurement: Goniometry. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAlireza Farrokhkia
Tabriz University of Medical Sciences
Outcome results
None listed